Viola Group has 1 portfolio company on record at Recent Funding. It led 1 of the 2 rounds it joined. Its most recent investment on record is Immunai's $60M Series A round in February 2021, alongside TLV Partners, Meron Capital, Duquesne Family Office and 3 others. That company is in Health and bio. It has co-invested with TLV Partners, Meron Capital and Catalio, most often TLV Partners (2 rounds).

What Viola Group invests in

• Health and bio · 1 · 100%
• Data and analytics · 1 · 100%
• Education · 1 · 100%

How Viola Group invests

Share is of the 2 rounds on Recent Funding that name Viola Group. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Viola Group portfolio companies

• IImmunai$60MSeries A · Feb 2021

Most frequent co-investors

• TTLV Partners2 shared rounds · last Feb 1, 2021
• MMeron Capital2 shared rounds · last Feb 1, 2021
• CCatalio1 shared round · last Feb 1, 2021
• DDuquesne Family Office1 shared round · last Feb 1, 2021
• DDexcel Pharma1 shared round · last Feb 1, 2021
• CCharles and Lynn Schusterman Family Philanthropies1 shared round · last Feb 1, 2021
• GGefen Capital1 shared round · last May 14, 2020

Similar investors

• 221501 company · 1 deal in 12 mo
• CCove Hill Partners1 company · 1 deal in 12 mo
• DDSW Ventures1 company · 1 deal in 12 mo
• NNorth Bridge Venture Partners & Growth Equity1 company
• CCastrum Capital2 companies · 2 deals in 12 mo
• SSelah Ventures2 companies · 2 deals in 12 mo

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

Portfolio companies are the companies on Recent Funding with a round that lists Viola Group, which is a subset of its real portfolio. API: /api/v1/investors/viola-group (get a free API key). More: the most active VC firms and new venture capital funds.